| Betterchem |
|
|
| FDA approval activities
for this prescription drug:
Omnipaque (iohexol) Injection, Amersham Health NDA 18-956/SLR-049 12/23/02 1/29/03 Omnipaque (iohexol) Injection, Amersham Health NDA 18-956/SLR-039 IOHEXOL Injection 30.2% OMNIPAQUE 140 AMERSHAM HLTH 018956 IOHEXOL Solution; Injection, 75.5% OMNIPAQUE 350 AMERSHAM HLTH 020608 IOHEXOL Solution; Injection, 75.5% OMNIPAQUE 350 AMERSHAM HLTH 018956 IOHEXOL Solution; Injection, , Rectal 38.8% OMNIPAQUE 180 AMERSHAM HLTH 018956 IOHEXOL Solution; Injection, , Rectal 51.8% OMNIPAQUE 240 AMERSHAM HLTH 020608 IOHEXOL Solution; Injection, , Rectal 51.8% OMNIPAQUE 240 AMERSHAM HLTH 020608 IOHEXOL Solution; Injection, , Rectal 64.7% OMNIPAQUE 300 AMERSHAM HLTH 018956 IOHEXOL Solution; Injection, , Rectal 64.7% OMNIPAQUE 300 AMERSHAM HLTH |
© 2007 Betterchem Corp.
|